Effects of β-endorphin and naloxone on in vitro maturation of bovine oocytes

Molecular Reproduction and Development

Volumn 63, Issue 2, 2002, Pages 210-222

  Dell'Aquila, M E ^a   Casavola, V ^a   Reshkin, S J ^a   Albrizio, M ^a   Guerra, L ^a   Maritato, F ^a   Minoia, P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

endorphin; Bovine oocyte; In vitro maturation; Intracellular calcium; MAP Kinase; Naloxone

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA ENDORPHIN; CALCIUM CHELATING AGENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MESSENGER RNA; METHYL GROUP; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MU OPIATE RECEPTOR; NALOXONE; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; 1,2-BIS(2-AMINOPHENOXY)ETHANE N,N,N',N'-TETRAACETIC ACID ACETOXYMETHYL ESTER; CALCIUM; CHELATING AGENT; DRUG DERIVATIVE; EGTAZIC ACID; ENZYME INHIBITOR; FLAVONOID; NARCOTIC ANTAGONIST;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATTLE; CELL CULTURE; CONTROLLED STUDY; CUMULUS OOPHORUS; DOSE RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC CODE; IN VITRO STUDY; INHIBITION KINETICS; MEIOSIS; METAPHASE; NONHUMAN; OOCYTE; OOCYTE MATURATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; GENETICS; GRANULOSA CELL; METABOLISM;

ANIMAL; BETA-ENDORPHIN; CALCIUM; CATTLE; CELL DIFFERENTIATION; CHELATING AGENTS; EGTAZIC ACID; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONES; GRANULOSA CELLS; IN VITRO; MEIOSIS; MITOGEN-ACTIVATED PROTEIN KINASES; NALOXONE; NARCOTIC ANTAGONISTS; OOCYTES; RECEPTORS, OPIOID, MU; SUPPORT, NON-U.S. GOV'T; ANIMALS; FLAVONOIDS;

BOVINAE;

EID: 0036771742     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrd.10163     Document Type: Article

References (63)

1. PD098059 is a specific inhibitor of activation of mitogenactivated protein kinase kinase in vitro and in vivo
2. In vitro maturation, fertilization of follicular oocytes in cattle
3. Amenorrea in drug dependance
4. The relationship between calcium, MAP Kinase, DNA synthesis in the sea urchin egg at fertilization
5. Mu-opioid receptor gene expression in immune cells
6. Induction and activation of mitogen-activated kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulphate
7. Endogenous opioid peptide receptors
8. Molecules involved in the metaphase I to metaphase II transition in mammalian oocytes
9. Gonadotropin response to Naloxone in the mare: Effect of time of year and reproductive status
10. Effects of Naloxone on in vitro maturation and cleavage of equine oocytes after intracytoplasmic sperm injection (ICSI)
11. + exchange by activating protein kinase C via the mobilization of intracellular calcium
12. What is stress and how does it affect reproduction
13. Effects of Naloxone on amphetamine induced striatal dopamine release in vivo: A microdialysis study
14. Potential role of mitogen-activated protein kinase during meiosis resumption in bovine oocytes
15. Embryonic development as a function of oocyte competence
16. In vitro developmental competence of embryos derived from transvaginal ultrasound oocyte aspiration in cycling cows and from slaughterhouse ovaries
17. Maturation promoting factor (MPF) and mitogen activated protein kinase (MAPK) expression in relation to oocyte competence for in vitro maturation in the horse
18. β-endorphin inhibition of progesterone secretion by porcine granulosa cells during follicle development
19. Opioid-effects on mitogen activated protein kinase signaling cascades
20. 3H] naloxone binding sites in porcine ovarian follicles and corpora lutea during the ovarian cycle
21. In vitro culture of bovine embryos in Menezo's B2 medium with or without coculture and serum: The normalcy of pregnancies and calves resulting from transferred embryos
22. Production, freezing and transfer of bovine IVF embryos and subsequent calving results
23. Calcium, calcium release receptors, and meiotic resumption in bovine oocytes
24. Bovine follicular development and its effect on the in vitro competence of oocytes
25. Partial agonists, full agonists, antagonists: Dilemmas of definition
26. Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: Biochemical and immunofluorescence confocal microscopic evidence
27. Blockade of ovulation by methadone in the rat: A central nervous system-mediated acute effect
28. Recent advances in molecular recognition and signaling transduction of active peptides: Receptors for opioid peptides
29. Potential local regulatory function of inhibins, activins and follistatin in the ovary
30. Requirement for the MAP kinase kinase/MAP kinase cascade in xenopus oocyte maturation
31. In vitro produced and cloned embryos: Effects on pregnancy parturition and offspring
32. Butirolactone I reversibly inhibits meiotic maturation of bovine oocytes, without influencing chromosome condensation activity
33. Morphine-induced inhibition of ovulation in normally cycling rats: Neural site of action
34. Interplay of maturation promoting factor and mitogen-activated protein kinase inactivation during metaphase-to-interphase transition of activated bovine oocytes
35. Differential inactivation of maturation promoting factor and mitogen activated protein kinase following parthenogenetic activation of bovine oocyte
36. Chronic morphine exposure increases the phosphorylation of MAP kinase and the transcription factor CREB in dorsal root ganglion neurons: An in vitro and in vivo study
37. Development of bovine oocytes matured with low concentration of gonadotropins and IGF-1 into advanced blastocyst stages after IVF
38. Induction of oocyte maturation
39. Calcium elevation in sheep cumulus-oocyte complexes after luteinizing hormone stimulation
40. Interplay between CDC2 kinase and MAP kinase pathway during maturation of mammalian oocytes
41. The effect of β-endorphin on rat oocyte maturation in vitro
42. Morphine inhibition of ovulation: Reversal by naloxone
43. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation
44. Neuroendocrine regulation of gonadotropins in the male and the female
45. Opioid analgesics and antagonists
46. Cellular localization of ovarian proopiomelanocortin messenger RNA during follicular and luteal development in the rat
47. Mechanism of action of narcotics in the production of menstrual dysfunction in women
48. Pregnancies, calves and calf viability after transfer of in vitro produced bovine embryos
49. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells
50. High level of endorphin and related pathologies of veterinary concern. A review
51. Effects of Naloxone on calcium turnover in cows affected by milk fever
52. Mechanism involved in the antiplatelet activity of Naloxone in human platelets
53. The kappa opioid receptor is present in porcine ovaries: Localization in granulosa cells
54. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity
55. Opioid receptor endocytosis and activation of MAP kinase
56. Maturation of human oocytes in vitro and their developmental competence
57. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures
58. Effect of intracellular calcium chelation with the acetoxymethylester-derived form of bis (o-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid on meiotic division and chromosomal segregation in mouse oocytes
59. Microtubule and chromatin behavior follow MAP kinase activity but not MPF activity during meiosis in mouse oocyte
60. The production of unusually large offspring following embryo manipulation: Concepts and challenges
61. Calmodulin binding to G protein-coupling domain of opioid receptors
62. The third extracellular loop of the mu-opioid receptor is important for agonist selectivity
63. The existence of inositol 1,4,5-trisphosphate and ryanodyne receptors in mature bovine oocytes